Details for New Drug Application (NDA): 205960
✉ Email this page to a colleague
The generic ingredient in ASENAPINE MALEATE is asenapine maleate. There are twelve drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the asenapine maleate profile page.
Summary for 205960
Tradename: | ASENAPINE MALEATE |
Applicant: | Breckenridge |
Ingredient: | asenapine maleate |
Patents: | 0 |
Suppliers and Packaging for NDA: 205960
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ASENAPINE MALEATE | asenapine maleate | TABLET;SUBLINGUAL | 205960 | ANDA | Breckenridge Pharmaceutical, Inc. | 51991-358 | 51991-358-11 | 10 BLISTER PACK in 1 BOX (51991-358-11) / 10 TABLET in 1 BLISTER PACK (51991-358-99) |
ASENAPINE MALEATE | asenapine maleate | TABLET;SUBLINGUAL | 205960 | ANDA | Breckenridge Pharmaceutical, Inc. | 51991-358 | 51991-358-60 | 6 BLISTER PACK in 1 BOX (51991-358-60) / 10 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | EQ 2.5MG BASE | ||||
Approval Date: | Dec 10, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Dec 10, 2020 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Mar 8, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription